Role of Iron Deficiency and Overload in the Pathogenesis of Diabetes and Diabetic Complications

被引:121
作者
Liu, Qiuju [1 ,2 ,3 ,6 ,7 ]
Sun, Liang [4 ,5 ]
Tan, Yi [1 ,2 ,3 ]
Wang, Guanjun [6 ]
Lin, Xu [4 ,5 ]
Cai, Lu [1 ,2 ,3 ,6 ]
机构
[1] Univ Louisville, Dept Med, Louisville, KY 40292 USA
[2] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40292 USA
[3] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China
[5] Chinese Acad Sci, Grad Univ, Shanghai, Peoples R China
[6] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China
[7] Jilin Univ, Hosp 2, Changchun 130023, Peoples R China
关键词
Diabetes; diabetic complications; insulin resistance; iron deficiency; iron overload; iron; ferritin; anemia; INSULIN-RESISTANCE SYNDROME; MITOCHONDRIAL-MEMBRANE PROTEIN; CORONARY-HEART-DISEASE; SERUM FERRITIN; ANGIOTENSIN-II; HEME OXYGENASE; BLOOD-DONATION; GLUCOSE-METABOLISM; UP-REGULATION; VITAMIN-A;
D O I
10.2174/092986709787002862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is one of the essential minerals that are required for a variety of molecules to maintain their normal structures and functions and for cells to live, grow, and proliferate. The homeostasis of iron results from a tightly coordinated regulation by different proteins involved in uptake, excretion and intracellular storage/trafficking. Although it is essential, iron can also be toxic once in excess amounts. Through Fenton reaction, iron as a transit mineral can generate various reactive oxygen or nitrogen species; therefore, abnormal metabolism of iron can lead to several chronic pathogenesis. Oxidative stress is one of the major causative factors for diabetes and diabetic complications. Increasing evidence has indicated that iron overload not only increases risks of insulin resistance and diabetes, but also causes cardiovascular diseases in non-diabetic and diabetic subjects. Temporal iron deficiency was found to sensitize insulin action, but chronic iron deficiency with anemia can accelerate the development of cardiovascular diseases in non-diabetic and diabetic patients. In this review, therefore, we will first outline iron homeostasis, function, and toxicity, and then mainly summarize the data regarding the roles of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications, as well as the possible links of iron to diabetes and diabetic complications. In the end, the possible therapy using iron chelators for diabetes and diabetic complications will also be discussed.
引用
收藏
页码:113 / 129
页数:17
相关论文
共 152 条
  • [1] Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study
    Acton, Ronald T.
    Reboussin, David M.
    Barton, James C.
    McLaren, Gordon D.
    Passmore, Leah V.
    Harris, Emily L.
    Adams, Paul C.
    Bent, Thomas C.
    Speechley, Mark R.
    Vogt, Thomas M.
    Castro, Oswaldo
    Sholinsky, Phyliss
    [J]. DIABETES CARE, 2006, 29 (09) : 2084 - 2089
  • [2] Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy
    Adaikalakoteswari, A.
    Balasubramanyam, M.
    Rema, M.
    Mohan, V.
    [J]. DIABETIC MEDICINE, 2006, 23 (06) : 666 - 674
  • [3] AFKHAMIARDEKANI M, 2008, J DIABETES COMPLICAT
  • [4] Al-Maroof RA, 2006, SAUDI MED J, V27, P344
  • [5] ZINC CONCENTRATION IN PATIENTS WITH IRON OVERLOAD RECEIVING ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE OR DESFERRIOXAMINE
    ALREFAIE, FN
    WONKE, B
    WICKENS, DG
    AYDINOK, Y
    FIELDING, A
    HOFFBRAND, AV
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) : 657 - 660
  • [6] Reduced insulin secretion in normoglycaemic patients with β-thalassaemia major
    Angelopoulos, N. G.
    Zervas, A.
    Livadas, S.
    Adamopoulos, I.
    Giannopoulos, D.
    Goula, A.
    Tolis, G.
    [J]. DIABETIC MEDICINE, 2006, 23 (12) : 1327 - 1331
  • [7] Ascic-Buturovic Belma, 2006, Bosn J Basic Med Sci, V6, P78
  • [8] Balamurugan R, 2007, Indian J Physiol Pharmacol, V51, P153
  • [9] Biliverdin reductase:: A major physiologic cytoprotectant
    Barañano, DE
    Rao, M
    Ferris, CD
    Snyder, SH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) : 16093 - 16098
  • [10] BEUTLER E, 2003, HEMATOL-AM SOC HEMAT, V40, P61